Heuron StroCare Suite

Organization
Heuron Co., Ltd. · South Korea
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Heuron Co., Ltd. was founded in 2017 and is headquartered in Seoul, South Korea, with offices in San Jose (US) and Singapore. The company develops medical AI for neurological disorders, focusing on acute stroke and neurodegenerative disease imaging.

Heuron StroCare Suite analyzes non-contrast CT images to detect suspected intracranial hemorrhage (ICH) and large vessel occlusion (ELVO) and to calculate ASPECTS scores, with additional CT angiography (CTA) and CT perfusion (CTP) modules. Analysis completes within minutes, notifies clinicians of critical findings, and results can be checked through PACS.

2. Highlighted features & specifications

  • Heuron ICH: Detects suspected intracranial hemorrhage on non-contrast head CT for triage.
  • Heuron ELVO: Identifies suspected large vessel occlusion on non-contrast CT.
  • Heuron ASPECTS: Identifies brain regions and calculates ASPECTS scores from non-contrast CT.
  • Heuron CTA and CTP: Analyze CT angiography and CT perfusion, with CTP reporting CBF, CBV, MTT, Tmax and mismatch.
  • Notification and PACS: Alerts clinicians to critical findings and shows results through PACS and a viewer.
  • Reports: Individual reports can be saved or printed to share with patients.

3. Potential application

Emergency departments of provincial hospitals in Vietnam can use CT-based triage to flag hemorrhage and large vessel occlusion before radiologist review. Hub-and-spoke stroke networks can route suspected thrombectomy candidates from primary centers to capable centers.

4. Benefits

Prioritizes emergency stroke patients through automatic triage and notification of critical findings. Analysis completes within minutes on non-contrast CT, which is available at most hospitals. Results are viewable in existing PACS and can be printed as reports. Regulatory approvals in several Asian markets ease adoption.

6. Other information

Founded 2017, Seoul. Series D of KRW 5 billion in 2025, Japan PMDA approval for StroCare Suite in 2025, Thailand joint venture, ISO 13485 and ISO 27001 certified. Distributors in Thailand and Taiwan, Raffles Hospital supply contract.

Heuron Co., Ltd.
View organization profile

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us